L. Cai, R. Xu, X. Guo, V. W. Pike
FULL PAPER
tored for absorbance at 254 nm (System Gold 168 detector;
Beckman, Fullerton, CA). The purity of each compound was ex-
from 9b (20 mg, 0.07 mmol). The crude product was dissolved in
DMF (2.0 mL) and purified by HPLC (aqueous NH3/MeCN, 73:27
v/v). Purity Ͼ 99%; yield 4.8 mg, 23%. 1H NMR (CDCl3): δ = 8.62
1
pressed as its area percentage of all chromatogram peak areas. H
NMR (400 MHz) and proton-decoupled 13C NMR (100 MHz) (s, 1 H, CHO), 8.09 (dm, 3JHH = 8.8 Hz, 2 H, Ar-H), 7.95 (d, 3JHH
4
spectra were acquired with an Avance 400 instrument (Bruker,
Billerica, MA) using the chemical shifts of residual deuterated sol-
vent as internal standard. Chemical shift (δ) data for the proton
and carbon resonances are reported in parts per million (ppm)
downfield relative to Me4Si; s, d, dd, brs, and dm denote singlet,
doublet, double doublet, broad singlet, and double multiplet,
respectively. LC–MS spectra were acquired with an LCQDECA in-
strument (Thermo Fisher Scientific, Waltham, MA) fitted with a
Luna C18 column (5 μm; 2.0ϫ150 mm; Phenomenex, Torrance,
CA) eluted at 150 μL/min with MeOH/H2O. HRMS were acquired
with either electron or electron spray ionization at the Mass Spec-
trometry Laboratory, University of Illinois at Urbana-
Champaign (Urbana, IL). An industrial ultrasonic processor
= 9.0 Hz, 1 H, Ar-H), 7.37 (d, JHH = 2.5 Hz, 1 H, Ar-H), 7.29
3
3
4
(dm, JHH = 8.8 Hz, 2 H, Ar-H), 7.11 (dd, JHH = 9.0, JHH
=
2.6 Hz, 1 H, Ar-H), 3.90 (s, 3 H, OCH3), 3.37 (s, 3 H, NCH3) ppm.
13C NMR (CDCl3): δ = 163.8 (CHO), 161.7, 157.7, 148.4, 143.6,
136.2, 131.4, 128.2, 123.5, 121.5, 115.6, 104.0, 55.6 (OCH3), 31.5
(NCH3) ppm. MS (TOF): m/z (%) = 301.1 (8), 300.1 (23), 299.0
(98) [M + H]+. HRMS: calcd. for C16H15N2O2S [M + H]+
299.0854; found 299.0850. Error (ppm): –1.3.
N-[4-(6-Bromobenzo[d]thiazol-2-yl)phenyl]formamide (9a): 4-(6-
Bromobenzo[d]thiazol-2-yl)aniline (7a, 20 mg, 0.06 mmol) was dis-
solved with ultrasonication in formic acid (1.0 mL). The solution
was placed in a microwave apparatus (Discover CEM, Matthews,
NC) at 120 °C for 10 min using 30 W power and a pressure limit
of 200 psi. After the reaction was complete, the solvent was evapo-
rated. The residue was washed with anhydrous diethyl ether to af-
ford crude 9a, which was dissolved in DMF (2.0 mL) and purified
by HPLC (aqueous NH3/MeCN, 17:83 v/v). Purity Ͼ 99%; yield
instrument (UIS250L, 250 W, 24 kHz; for
a
description,
exhibitor_19738.pdf), was used to agitate heterogeneous radioac-
tive reaction mixtures in closed vials. These vials (1 mL volume)
and their caps were custom-made from inert fluoropolymers. The
reaction vial was designed to fit snugly into the port of the instru-
ment so that ultrasound was efficiently transmitted to the reaction
mixture. In order to allow reagents to be added and reaction mix-
tures to be sampled, the septum liner of the vial cap was designed
to withstand multiple needle punctures without leaking.
1
5.5 mg, 25%. H NMR (CDCl3): δ = 10.6 (br. s, 1 H, NH), 8.44
3
3
(d, JHH = 1.9 Hz, 1 H, CHO), 8.37 (d, JHH = 1.6 Hz, 1 H, Ar-
3
3
H), 8.07 (d, JHH = 8.7 Hz, 2 H, Ar-H), 7.96 (d, JHH = 8.6 Hz, 1
H, Ar-H), 7.79 (d, JHH = 8.7 Hz, 2 H, Ar-H), 7.68 (dd, JHH
3
3
=
8.7, JHH = 2.0 Hz, 1 H) ppm. 13C NMR (CDCl3): δ = 167.8
(CHO), 160.1, 152.6, 141.2, 136.3, 129.7, 128.3, 124.8, 124.1, 119.5,
117.8, 117.3 ppm. MS (TOF): m/z (%) = 336.9 (5), 335.9 (21), 334.9
(98), 332.9 (93) [M + H]+. HRMS: calcd. for C14H10BrN2OS [M +
H]+ 332.9697; found 332.9697. Error (ppm): 0.
4
Chemical Syntheses: The following compounds were synthesized
as published: 4-(6-bromobenzo[d]thiazol-2-yl)-N-methylaniline
(1a),[11] 4-(6-methoxybenzo[d]thiazol-2-yl)-N-methylaniline (1b),[11]
3-(13-methyl-7-oxo-6,7-dihydro-5H-indolo[2,3-a]pyrrolo[3,4-c]-
carbazol-12(13H)-yl)propanenitrile (2),[41,42] N-methyl-4-nitro-
aniline (4c),[43] N-methyl-N-(3-nitrophenyl)formamide (5a),[44] N-
methyl-N-(2-nitrophenyl)formamide (5b),[45] N-methyl-N-(4-ni-
trophenyl)formamide (5c),[44] 4-(6-bromobenzo[d]thiazol-2-yl)-
aniline (7a),[11] 4-(6-methoxybenzo[d]thiazol-2-yl)aniline (7b),[11]
methyl 8-amino-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate
(10d),[45] methyl 3-methoxy-4-(methylamino)benzoate (11b),[46–48]
methyl 2-methoxy-4-(methylamino)benzoate (11c),[46,47] methyl 8-
(methylamino)-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxylate
(11d),[44,45] and 3-(7-oxo-6,7-dihydro-5H-indolo[2,3-a]pyrrolo-
[3,4-c]carbazol-12(13H)-yl)propanenitrile (12).[41,42]
N-[4-(6-Methoxybenzo[d]thiazol-2-yl)phenyl]formamide (9b): The
method used to synthesize 9a was used with 4-(6-methoxybenzo-
[d]thiazol-2-yl)aniline (7b, 20 mg, 0.07 mmol) to give crude 9b,
which was dissolved in DMF (2.0 mL) and purified by HPLC
(aqueous NH3/MeCN, 13:87 v/v). Purity Ͼ 99%; yield 5.3 mg,
1
3
24%. H NMR (MeOD): δ = 8.66 (s, 1 H, CHO), 8.12 (dm, JHH
3
= 8.7 Hz, 2 H, Ar-H), 7.91 (d, JHH = 9.0 Hz, 1 H, Ar-H), 7.56 (d,
4JHH = 2.5 Hz, 1 H, Ar-H), 7.49 (dm, JHH = 8.7 Hz, 2 H, Ar-H),
3
3
4
7.15 (dd, JHH = 9.0, JHH = 2.6 Hz, 1 H, Ar-H), 3.92 (s, 3 H,
OCH3) ppm. 13C NMR (CD3OD): δ = 166.1 (CHO), 164.2, 159.8,
149.5, 145.6, 138.6, 132.6, 129.4, 124.3, 123.2, 117.3, 105.3, 56.4
(OCH3) ppm. MS (TOF): m/z (%) = 362.1 (25), 360.1, 324.1 (100),
285.1 (90) [M + H]+. HRMS: calcd. for C15H13N2O2S [M]+
285.0698; found 285.0696. Error (ppm): –0.7.
N-[4-(6-Bromobenzo[d]thiazol-2-yl)phenyl]-N-methylformamide (8a):
N-Formylarylamine 9a (20 mg, 0.06 mmol), Li3N (5 mg,
0.14 mmol), and CH3I (5 μL, 0.08 mmol) were suspended in DMF
(0.5 mL). The suspension was placed in the ultrasonic device, which
was set at full power level for half of a 30 min period. The reaction
mixture was then quenched with aqueous HCOONH4 (5 m,
0.5 mL). The solvent was evaporated, and the residue was dissolved
in DMF. The product 8a was separated by HPLC (aqueous
General Radiochemistry Procedure: No-carrier-added (NCA) [11C]-
carbon dioxide was prepared by the 14N(p,α)11C nuclear reaction
by irradiation of nitrogen gas (164 psi) that contained oxygen (1%)
with protons (16.5 MeV, 45 μA) generated with a cyclotron (PET-
trace 200; GE Healthcare, Milwaukeee, WI). Radiochemistry was
performed in lead-shielded hot-cells for radiation protection to per-
sonnel. The [11C]carbon dioxide was converted in an automated
apparatus (PETrace MeI MicroLab; GE) into [11C]methyl iodide
by reduction to [11C]methane followed by a gas-phase reaction with
iodine. Within an inert glovebox (oxygen Ͻ 10 ppm and moist-
ure Ͻ 0.5 ppm), solid inorganic-base (ca. 5 mg), substrate (1.0 mg)
and solvent (0.3 mL) were loaded into a fluoropolymer reaction
vial (volume 1 mL) and the vial crimp-sealed with a fluoropolymer
septum. NCA [11C]methyl iodide (ca. 100 mCi) in nitrogen carrier
gas was then bubbled into the reaction mixture. The sealed vial was
placed in the port of the ultrasound apparatus (Ultrasonic Proces-
sor, UIS250L) and irradiated at full power for 50% of the time,
unless otherwise indicated, for a set period (Յ 10 min). The reac-
1
NH4OH/MeCN, 49:51 v/v). Purity Ͼ 98%; yield 4.2 mg, 20%. H
3
NMR (CDCl3): δ = 8.65 (s, 1 H, CHO), 8.12 (dm, JHH = 8.6 Hz,
4
3
2 H, Ar-H), 8.05 (d, JHH = 1.8 Hz, 1 H, Ar-H), 7.92 (d, JHH
=
3
4
8.6 Hz, 1 H, Ar-H), 7.61 (dd, JHH = 8.7, JHH = 1.9 Hz, 1 H, Ar-
H), 7.30 (dm, JHH = 8.6 Hz, 2 H, Ar-H), 3.41 (s, 3 H, NCH3)
3
ppm. 13C NMR (CDCl3): δ = 167.1 (CHO), 161.9, 153.0, 144.6,
136.7, 130.9, 130.1, 128.8, 124.3, 124.2, 121.7, 119.0, 31.7 (NCH3)
ppm. MS (TOF): m/z (%) = 163.0 (5), 350.9 (5), 165.0 (7), 381.2
(13), 349.9 (21), 346.9 (98) [M + H]+. HRMS: calcd. for
C15H12BrN2OS [M + H]+ 346.9854: found 346.9850. Error (ppm):
–1.2.
N-[4-(6-Methoxybenzo[d]thiazol-2-yl)phenyl]-N-methylformamide
(8b): The method used to synthesize 8a was used to prepare 8b
1308
www.eurjoc.org
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2012, 1303–1310